Does positron emission tomogrpahy have a role in routine clinical practice in patients with Hodgkin's disease?

Clin Lymphoma. 2002 Sep;3(2):125-6. doi: 10.1016/s1526-9655(11)70258-5.

Authors

Guy H M Jerusalem¹, Yves P Beguin

Affiliation

¹ Department of Medicine, Division of Oncology-Hematology, University of Liège, Liège, Belgium.

PMID: 12435287
DOI: 10.1016/s1526-9655(11)70258-5

No abstract available

MeSH terms

Fluorodeoxyglucose F18
Hodgkin Disease / diagnosis*
Hodgkin Disease / pathology
Humans
Neoplasm Staging / methods
Radiopharmaceuticals
Tomography, Emission-Computed / methods*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18